Independent Neurophysiology Analytics and Research Support
About Neuromap™
Neuromap™ is a proprietary EEG and qEEG analytics platform developed within the Cosmos Healthcare research and clinical ecosystem in London, United Kingdom.
Why Neuromap™ was developed
Advanced EEG research often requires outputs that are distributed across separate software packages, manual calculations, quality-control processes and disconnected reports. Neuromap™ was developed to organise technically suitable EEG data into a coherent, traceable analytical framework that can support research, longitudinal monitoring and scientific interpretation.
Our research purpose
- Make advanced EEG and qEEG analysis accessible to research teams without an internal specialist laboratory.
- Support high-volume and repeated-measurement studies with consistent workflows.
- Bring technical quality, quantitative analysis, longitudinal context and specialist review into one coordinated service.
- Improve transparency through documented methods, limitations, data dictionaries and version control.
- Support collaboration across CROs, sponsors, universities, hospitals and neurotechnology teams.
Scientific leadership
Neuromap™ was developed under the leadership of Dr Alptekin Aydın, specialist neuropsychologist and neuroscience researcher with experience in qEEG-guided clinical work, neuromodulation, research and medico-legal practice. Dr Aydın is the founder of Cosmos Healthcare Ltd. His verified research record is linked through ORCID 0000-0002-9470-1953 and the Publications & Evidence page.
The wider Cosmos Healthcare ecosystem
Neuromap™ operates alongside complementary technologies within the Cosmos Healthcare ecosystem. EdfCheck™ supports recording and file-integrity workflows. QPAN™ supports separate neuromodulation research and protocol-development functions. ClinicOS supports operational and data-workflow functions. Clinical, research and software outputs are separated according to intended purpose, evidence, governance and contractual scope.
Our working principles
Data quality before interpretation
Analytical sophistication cannot compensate for unsuitable or poorly documented input data.
Protocol-specific analysis
The research question determines the analytical plan, not the maximum number of available outputs.
Transparent methods and limitations
Variables, reference context, exclusions, uncertainty and interpretation boundaries are documented.
Human scientific oversight
Automation supports scale and consistency while qualified people retain accountability for agreed review and interpretation.
Longitudinal and reproducible workflows
Repeated analysis uses controlled configurations and traceable changes.
Responsible AI
AI-assisted methods are used with data minimisation, risk assessment, transparency, security and appropriate human oversight.
Research governance
Privacy, consent, ethics, GCP responsibilities and sponsor oversight are respected within the applicable project framework.
Proportionate claims
Findings are described at the evidence level they support; exploratory outputs are never presented as validated diagnostic or regulatory endpoints.
Security and data minimisation
Participant data are handled through approved secure routes with role-based access, using only the metadata required for the agreed analysis.
How we work with partners
Engagement begins with feasibility. Neuromap™ reviews the study question, acquisition design, representative files, expected volume, deliverables and governance requirements. The agreed work is then documented through the appropriate confidentiality, services, data-processing and study-specific agreements. Production begins only after compatibility and acceptance criteria are defined.
Research collaboration
Neuromap™ welcomes appropriately governed collaboration involving methods validation, pilot studies, multi-site research, candidate biomarker development, grant applications, intervention evaluation, neurotechnology integration and scientific publication. Collaboration proposals are assessed for scientific merit, data suitability, governance, resource requirements and conflicts of interest.
Frequently asked questions
Common questions about Neuromap™.
Is Neuromap™ part of Cosmos Healthcare?
Neuromap™ was developed within the Cosmos Healthcare research and clinical ecosystem. Contracting and legal-entity details are confirmed in each formal engagement.
Is Neuromap™ only for clinical services?
No. This website is focused on research analytics, clinical trials, translational research and scientific collaboration.
Does the platform replace a neuroscientist?
No. Computational processing supports scale and consistency. Human review and accountability are defined according to the project scope.